Neuberger Berman High Yield Strategies Fund Inc. NHS
We take great care to ensure that the data presented and summarized in this overview for Neuberger Berman High Yield Strategies Fund Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding NHS
View all-
Morgan Stanley New York, NY699KShares$5.49 Million0.0% of portfolio
-
Guggenheim Capital LLC Chicago, IL691KShares$5.43 Million0.04% of portfolio
-
Lpl Financial LLC Fort Mill, SC564KShares$4.43 Million0.0% of portfolio
-
Granite Shares Advisors LLC233KShares$1.83 Million1.39% of portfolio
-
Wells Fargo & Company San Francisco, CA201KShares$1.58 Million0.0% of portfolio
-
Uncommon Cents Investing LLC182KShares$1.43 Million0.45% of portfolio
-
Invesco Ltd. Atlanta, GA181KShares$1.42 Million0.0% of portfolio
-
Melfa Wealth Management, LLC Westborough, MA92.2KShares$724,6290.53% of portfolio
-
J.W. Cole Advisors, Inc.88.9KShares$698,3610.03% of portfolio
-
High Tower Advisors, LLC Chicago, IL78.8KShares$619,3520.0% of portfolio
Latest Institutional Activity in NHS
Top Purchases
Top Sells
About NHS
Neuberger Berman High Yield Strategies Fund Inc. is a closed-ended fixed income mutual fund launched by Neuberger Berman LLC. The fund is managed by Neuberger Berman Investment Advisers LLC. It invests in fixed income markets across the globe. The fund typically invests in high yield debt securities of various sectors, such as auto parts and equipment, airlines, automotive, electronics, health services, packaging, telecom-integrated/services, gaming, and gas distribution. It was formerly known as Neuberger Berman High Yield Strategies Fund. Neuberger Berman High Yield Strategies Fund Inc. was formed on July 28, 2003 and is domiciled in the United States.
Insider Transactions at NHS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2023
|
Met Life Investment Management, LLC |
SELL
Other acquisition or disposition
|
Indirect |
6,080,000
-100.0%
|
-
|
|
Sep 18
2023
|
Met Life Investment Management, LLC |
SELL
Other acquisition or disposition
|
Indirect |
26,500,000
-100.0%
|
-
|
|
Sep 18
2023
|
Met Life Investment Management, LLC |
SELL
Other acquisition or disposition
|
Indirect |
19,500,000
-100.0%
|
-
|
|
Jul 03
2023
|
Bradley Tank |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
52,176
+25.0%
|
$365,232
$7.42 P/Share
|
|
Jul 03
2023
|
Bradley Tank |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
67,472
+25.0%
|
$472,304
$7.42 P/Share
|
|
Jul 03
2023
|
Joseph Lind |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
5,833
+15.22%
|
$40,831
$7.42 P/Share
|
|
Jun 21
2023
|
George W Morriss |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3,422
+20.0%
|
$23,954
$7.42 P/Share
|
|
Jun 21
2023
|
Bradley Tank |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
26,088
+20.0%
|
$182,616
$7.42 P/Share
|
|
Jun 21
2023
|
Bradley Tank |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
33,736
+20.0%
|
$236,152
$7.42 P/Share
|
|
Jun 21
2023
|
Joseph Lind |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
6,667
+20.0%
|
$46,669
$7.42 P/Share
|
|
Jun 07
2022
|
Joseph Lind |
BUY
Open market or private purchase
|
Direct |
5,000
+20.0%
|
$45,000
$9.14 P/Share
|
|
Jun 06
2022
|
Joseph Lind |
BUY
Open market or private purchase
|
Direct |
5,000
+25.0%
|
$45,000
$9.25 P/Share
|
|
Jun 03
2022
|
Met Life Investment Management, LLC |
BUY
Open market or private purchase
|
Indirect |
26,500,000
+50.0%
|
-
|
|
May 17
2022
|
Joseph Lind |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
5,000
+25.0%
|
$40,000
$8.6 P/Share
|
|
May 17
2022
|
George W Morriss |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
3,763
+29.25%
|
$30,104
$8.6 P/Share
|
|
May 17
2022
|
Bradley Tank |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
19,565
+20.0%
|
$156,520
$8.6 P/Share
|
|
May 17
2022
|
Bradley Tank |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
25,301
+20.0%
|
$202,408
$8.6 P/Share
|
|
Dec 14
2020
|
Met Life Investment Management, LLC |
SELL
Other acquisition or disposition
|
Indirect |
1,520,000
-20.0%
|
$3,352,629,040,000
$2205677.0 P/Share
|
|
Dec 14
2020
|
Met Life Investment Management, LLC |
SELL
Other acquisition or disposition
|
Indirect |
10,500,000
-35.0%
|
$36,858,748,500,000
$3510357.0 P/Share
|
|
Dec 14
2020
|
Saba Capital Management, L.P. > 10% Shareholder |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
3,572,083
-74.81%
|
$42,864,996
$12.03 P/Share
|